Surgery Partners, Inc.
Surgery Partners, Inc. (SGRY) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
sgry · stock forecast · 22 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 22 Wall Street analysts in the past 3 months
Buy
22 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$21.00
Consensus
$19.25
+40.4% upside
Low
$17.00
Median: $19.5 · Last Close: $13.71
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$19.25
40.4% upside
High Target
$21
53.2%
Low Target
$17
24.0%
Current Price
$13.71
as of today
Based on analyst price targets, the SGRY stock price prediction for the next 12 months ranges from $17 to $21. The consensus SGRY price forecast of $19.25 implies 40.4% upside from the current price of $13.71.
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $13.61 | ↓ 0.70% |
1-day model range: $13.56–$13.66. Peak: $13.66 (-0.70%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $8 | -40.3% |
| 2028 | $6 | -53.6% |
| 2029 | $6 | -59.2% |
| 2030 | $5 | -62.0% |
| 2031 | — | -63.4% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · SGRY · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-03-05 | TD Cowen | Maintains | Buy→Buy |
| 2026-03-05 | UBS | Maintains | Buy→Buy |
| 2026-03-05 | Mizuho | Maintains | Outperform→Outperform |
| 2026-03-04 | RBC Capital | Maintains | Outperform→Outperform |
| 2026-03-03 | Barclays | Maintains | Equal Weight→Equal Weight |
| 2025-12-18 | Mizuho | Maintains | Outperform→Outperform |
| 2025-11-24 | JP Morgan | Maintains | Neutral→Neutral |
| 2025-11-21 | Barclays | Maintains | Equal Weight→Equal Weight |
| 2025-11-17 | Mizuho | Maintains | Outperform→Outperform |
| 2025-11-13 | UBS | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Surgery Partners, Inc. (SGRY) stock. Of the recent 118 rating actions, 8 were upgrades and 12 were downgrades. 22 analysts currently cover SGRY.
Analyst Recommendation Trends
SGRY analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 4 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$3.3B
↓ 8.3% YoY
Revenue Next Year
$3.4B
↑ 3.6% YoY
EPS This Year
$0.63
EPS Next Year
$0.41
↓ 34.8% YoY
EPS ForecastReported vs Estimated
Analysts forecast SGRY EPS of $0.63 for the current fiscal year, based on estimates from 7 analysts. The SGRY revenue forecast is $3.3B for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The SGRY stock forecast is supported by two independent data sources: analyst consensus ratings from 22 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus SGRY price target is $19.25 (+40.4% upside), with an analyst consensus of Buy.
The SGRY short-term stock prediction for tomorrow is $13.61 (-0.70%). The SGRY stock price prediction for 2027 estimates an average of $8. The SGRY stock prediction for 2030 projects a range of $5–$5.
Surgery Partners, Inc. trades on NASDAQ under the ticker SGRY. The SGRY stock outlook for 2027 is broadly positive, supported by a Buy consensus among 64% of covering analysts.
Frequently asked questions
SGRY forecast · 8 questionsAccording to 22 Wall Street analysts, the average 12-month SGRY price target is $19.25, with a high forecast of $21.00 and a low of $17.00. The median price target is shown in the chart above when available. This implies +40.4% potential upside from the current price of $13.71.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.